Abdomino-pelvic hypertherma and intraperitoneal carboplatin in epithelial ovarian cancer: Feasibility, tolerance and pharmacology
- 15 July 1996
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 35 (5) , 993-1001
- https://doi.org/10.1016/0360-3016(96)00092-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.Journal of Clinical Oncology, 1992
- Intraperitoneal therapy for ovarian cancer: Analysis of fluid distribution by computerized tomographyAnnals of Oncology, 1992
- Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: Report of a pilot study by the Radiation Therapy Oncology GroupInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in ratsEuropean Journal of Cancer and Clinical Oncology, 1991
- Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.Journal of Clinical Oncology, 1990
- Heat sensitization to cisplatin in two cell lines with different drug sensitivitiesInternational Journal of Hyperthermia, 1990
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexesInternational Journal of Radiation Oncology*Biology*Physics, 1989